CD276 and brain neoplasm: This study presents a novel approach to brain tumor immunotherapy, utilizing biodegradable PBAE nanoparticles to deliver DNA encoding the costimulatory molecule 4‐1BBL and the cytokine IL‐12 to brain tumors.